Dayal Viswas, Limousin Patricia, Foltynie Thomas
J Parkinsons Dis. 2017;7(2):235-245. doi: 10.3233/JPD-171077.
Subthalamic Nucleus Deep Brain Stimulation (STN DBS) is a well-established and effective treatment modality for selected patients with Parkinson's disease (PD). Since its advent, systematic exploration of the effect of stimulation parameters including the stimulation intensity, frequency, and pulse width have been carried out to establish optimal therapeutic ranges. This review examines published data on these stimulation parameters in terms of efficacy of treatment and adverse effects. Altering stimulation intensity is the mainstay of titration in DBS programming via alterations in voltage or current settings, and is characterised by a lower efficacy threshold and a higher side effect threshold which define the therapeutic window. In addition, much work has been done in exploring the effects of frequency modulation, which may help patients with gait freezing and other axial symptoms. However, there is a paucity of data on the use of ultra-short pulse width settings which are now possible with technological advances. We also discuss current evidence for the use of novel programming techniques including directional and adaptive stimulation, and highlight areas for future research.
丘脑底核深部脑刺激术(STN DBS)是一种针对特定帕金森病(PD)患者行之有效的成熟治疗方式。自其问世以来,人们对包括刺激强度、频率和脉宽在内的刺激参数的效果进行了系统探索,以确定最佳治疗范围。本综述根据治疗效果和不良反应,审视了有关这些刺激参数的已发表数据。通过改变电压或电流设置来改变刺激强度是DBS程控滴定的主要方法,其特点是疗效阈值较低,副作用阈值较高,二者共同界定了治疗窗口。此外,在探索频率调制的效果方面已开展了大量工作,这可能有助于改善步态冻结及其他轴性症状的患者。然而,随着技术进步现在已可实现的超短脉宽设置方面的数据却很匮乏。我们还讨论了使用包括定向和自适应刺激在内的新型程控技术的现有证据,并突出了未来的研究方向。